ROVI — Laboratorios Farmaceuticos Rovi Share News
0.000.00%
Last trade - 00:00- €2.95bn
- €2.94bn
- €743.48m
Spanish stocks - Factors to watch on July 23
Brief: Rovi H1 Net Profit €84.5 Mln
Brief: ROVI H1 Revenue EUR 344.2 Million
Europe Research Roundup: Belimo Holding, CTS Eventim, HSBC
Spanish stocks - Factors to watch on May 13 (updated)
Spanish stocks - Factors to watch on May 13
Rovi falls after cutting 2026 operating revenue outlook
Spanish stocks - Factors to watch on May 6 (updated)
Brief: Rovi Q1 Net Profit At 9.4 Mln Euros
Brief: Rovi Expects Risperidone To Reach Potential Sales Of 100-200 Mln Euros Globally Over Next Few Years
Brief: ROVI Q1 Revenue EUR 152.5 Million
Spanish stocks - Factors to watch on May 6
Brief: Rovi Closes Deal To Buy Pharmaceutical Manufacturing Facility In US
Jefferies cuts Rovi to 'hold' as visibility fades, risks mount
Europe Research Roundup: Asta Energy Solutions, Forvia, Grenergy
Spanish stocks - Factors to watch on March 11
Rovi rises on full-year earnings beat
Drugmaker Rovi's net profit rises on higher Okedi, heparin sales
Spanish stocks - Factors to watch on Feb 25 (updated)